Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4853268
Max Phase: Preclinical
Molecular Formula: C42H48O9
Molecular Weight: 696.84
Molecule Type: Unknown
Associated Items:
ID: ALA4853268
Max Phase: Preclinical
Molecular Formula: C42H48O9
Molecular Weight: 696.84
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc([C@@H]2c3cc4c(cc3[C@H](OC(=O)/C=C(C)/C=C/C=C(C)/C=C/C3=C(C)CCCC3(C)C)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC
Standard InChI: InChI=1S/C42H48O9/c1-24(14-15-31-26(3)13-10-16-42(31,4)5)11-9-12-25(2)17-36(43)51-39-29-21-33-32(49-23-50-33)20-28(29)37(38-30(39)22-48-41(38)44)27-18-34(45-6)40(47-8)35(19-27)46-7/h9,11-12,14-15,17-21,30,37-39H,10,13,16,22-23H2,1-8H3/b12-9+,15-14+,24-11+,25-17+/t30-,37+,38-,39-/m0/s1
Standard InChI Key: OAVIEEUZOVJJPY-FVPKWZMISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 696.84 | Molecular Weight (Monoisotopic): 696.3298 | AlogP: 8.49 | #Rotatable Bonds: 10 |
Polar Surface Area: 98.75 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.53 | CX LogD: 7.53 |
Aromatic Rings: 2 | Heavy Atoms: 51 | QED Weighted: 0.14 | Np Likeness Score: 1.91 |
1. Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F.. (2020) Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020)., 208 [PMID:32992133] [10.1016/j.ejmech.2020.112830] |
Source(1):